hardprolactinrisperidonehyperprolactinemiagalactorrheaamenorrheabone densityantipsychotic side effects
A 33-year-old female with schizophrenia has been stable on risperidone 4 mg daily for 14 months. She presents reporting new-onset galactorrhea, oligomenorrhea over the past three months, and decreased libido. Laboratory results show a prolactin level of 89 ng/mL (normal: 2-29 ng/mL for females). Her psychiatric symptoms remain well-controlled with a BPRS score of 24. She is distressed by the symptoms and reports they are affecting her intimate relationship. A pregnancy test is negative. The PMHNP is evaluating the significance of these findings and determining the appropriate clinical response. Which of the following best represents the accurate evaluation of this clinical scenario?